Press "Enter" to skip to content

Pfizer and BioNTech seeks FDA Approval for kids aged 5-11

Pfizer and BioNTech have asked the U.S. FDA to approve emergency use of coronavirus vaccination for kids aged from 5 to 11. So far, vaccination is approved for children aged 12 and older.

Pfizer and BioNTech coronavirus vaccines for Americans who are aged 16 and older have been permitted by Food and Drug Administration (FDA). Last month, they have presented data to the health regulatory from a clinical trial on the effectiveness of the vaccine for children.

For the kids aged 5-11, the pharmaceutical company has tested a much lower dose of the vaccination. Although, the children’s have established COVID-19 fighting antibodies as sturdy as teenagers and adults who are getting the regular vaccination dose

Pfizer and BioNTech seeks FDA Approval for kids aged 5-11

Dr. Bill Gruber, a Pfizer senior vice president said that kids’ doses have demonstrated safe, with side effects comparable to fever, sore arms, or achiness. Cases in the children have grown due to the Delta variant.

As per the American Academy of Pediatrics, more than 5 million children in the U.S. have been tested positive for COVID-19 but the kids are at lower risk of severe illness or death compared to older people.

California became the first state in the U.S. to necessitate coronavirus vaccination for children to attend private and public schools in person. Any student who declines vaccination without any exemption would be required to do study at home independently. Exclusions will be given for medical reasons or personal or religious philosophies.